<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03188263</url>
  </required_header>
  <id_info>
    <org_study_id>STU00204710</org_study_id>
    <nct_id>NCT03188263</nct_id>
  </id_info>
  <brief_title>Morning Light Treatment to Improve Glucose Metabolism</brief_title>
  <acronym>ML</acronym>
  <official_title>Morning Light Treatment at Home to Improve Glucose Metabolism in People at Increased Risk for Type 2 Diabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Rush University</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The primary purpose of this pilot study is to test a novel head worn light device (Re-Timer®)&#xD;
      as an intervention to improve glucose metabolism in people with prediabetes. The hypothesis&#xD;
      is that morning light treatment will improve glucose metabolism. This is a pilot study and&#xD;
      the data from this project will be used to develop a larger clinical trial.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is a pilot study to determine whether light treatment can improve glucose metabolism in&#xD;
      people with prediabetes. Individuals will be asked to complete a baseline session with&#xD;
      one-week of at-home sleep monitoring followed by a 24-hour stay in the clinical research&#xD;
      unit. During this stay, we will sample saliva in the evening to measure melatonin to estimate&#xD;
      the timing of the internal biological clock (&quot;circadian phase&quot;) and then we will perform a&#xD;
      3-hour oral glucose tolerance test in the morning to estimate markers of glucose metabolism,&#xD;
      including insulin sensitivity. The participants will then be given a light device and&#xD;
      instructed on its use. They will use the device for four weeks and visit our laboratory every&#xD;
      week for a check-in. At the end of the four weeks, they will repeat the 24-hour stay in the&#xD;
      clinical research unit.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">September 5, 2017</start_date>
  <completion_date type="Actual">December 31, 2019</completion_date>
  <primary_completion_date type="Actual">December 31, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>half will receive active light treatment device, the other half will receive a placebo device</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in Glucose Levels (Area-under-the-curve) Measured by Performance on Oral Glucose Tolerance Test (OGTT)</measure>
    <time_frame>Change from baseline to after 4 weeks of light treatment</time_frame>
    <description>The OGTT is a 3-hour procedure measuring blood glucose levels after the patient has consumed a 75-gram dextrose solution at -15 min, 0 min, 30 min, 60 min, 90 min, 120 min, and 180 min intervals. Total area-under-the-curve of glucose levels is calculated.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Changes in Circadian Phase Measured by Dim Light Melatonin Onset (DLMO)</measure>
    <time_frame>Change from baseline to after 4 weeks of light treatment.</time_frame>
    <description>The DLMO is measured via saliva samples collected during laboratory sessions. A sample is collected every half hour until bedtime starting 6.5 hours before habitual bedtime, and conducted in dim light setting to identify the point when melatonin starts being released.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">10</enrollment>
  <condition>PreDiabetes</condition>
  <condition>Circadian Dysregulation</condition>
  <arm_group>
    <arm_group_label>Bright Light</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Irradiance is 230 μW/m2 and lux is 500 lux.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dim Light</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>irradiance is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Bright Light</intervention_name>
    <description>1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance is 230 μW/m2 and lux is 500 lux.</description>
    <arm_group_label>Bright Light</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Dim Light</intervention_name>
    <description>1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance in this dimmed is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux</description>
    <arm_group_label>Dim Light</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria: 34 subjects (50% female, age 40-65 y)&#xD;
&#xD;
        Subjects will be:&#xD;
&#xD;
          -  Prediabetic (HbA1c 5.7% to &lt;6.5%)&#xD;
&#xD;
          -  overweight or obese (BMI&gt;25 kg/m2)&#xD;
&#xD;
          -  be free of moderate to severe obstructive sleep apnea (apnea-hypopnea index&lt;30).&#xD;
&#xD;
        The laboratory sessions will occur during women's follicular phase or women will be&#xD;
        postmenopausal (≥6 months since last menses).&#xD;
&#xD;
        Subjects will be scheduled to participate ≥ 1 month from travel outside the central time&#xD;
        zone, and during a time with minimal special events.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Women who are pregnant, planning on becoming pregnant, or are breastfeeding.&#xD;
&#xD;
          -  Women on oral contraceptives or hormone replacement therapy will be excluded (alters&#xD;
             OGTT and melatonin).&#xD;
&#xD;
          -  Men and women who have a child at home that does not sleep through the night will be&#xD;
             excluded.&#xD;
&#xD;
          -  Adults unable to consent, individuals who are not yet adults (infants, children,&#xD;
             teenagers), pregnant women, and prisoners are also excluded.&#xD;
&#xD;
          -  History of any form of diabetes, including use of diabetes medications&#xD;
&#xD;
          -  Age outside 35-70 years (we will not enroll anyone older than 70 years because of a&#xD;
             reduced response to light).&#xD;
&#xD;
          -  Smokers&#xD;
&#xD;
          -  Shift workers&#xD;
&#xD;
          -  Failed urine drug test (drugs of abuse, nicotine)&#xD;
&#xD;
          -  Eye disease/photosensitizing medications&#xD;
&#xD;
          -  Sleep medications, diagnosed sleep disorders (history of treatment may affect glucose&#xD;
             metabolism),&#xD;
&#xD;
          -  Daily beta-blocker, NSAID or melatonin use (confounds DLMO)&#xD;
&#xD;
          -  History of psychiatric disorders (confounds effect of light treatment, per relevant&#xD;
             items from Mood Disorder, Psychotic Screening and Substance Use Disorders Modules of&#xD;
             the Structured Clinical Interview for DSM-IV Axis I Disorders - Non-Patient Edition&#xD;
             (SCID-IV/NP) to screen for schizophrenia, bipolar depression, substance abuse,&#xD;
             suicidal ideation, obsessive compulsive disorder, PTSD), depressive symptoms using the&#xD;
             Center for Epidemiologic Studies - Depression (CES-D) scale&#xD;
&#xD;
          -  Irregular menses&#xD;
&#xD;
          -  History of cardiovascular disease (excluding hypertension), endocrine, kidney,&#xD;
             gastrointestinal or liver disorder, seizures, and cancer.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>35 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Kristen Knutson, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2020</verification_date>
  <study_first_submitted>June 1, 2017</study_first_submitted>
  <study_first_submitted_qc>June 14, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">June 15, 2017</study_first_posted>
  <results_first_submitted>December 1, 2020</results_first_submitted>
  <results_first_submitted_qc>December 28, 2020</results_first_submitted_qc>
  <results_first_posted type="Actual">December 29, 2020</results_first_posted>
  <last_update_submitted>December 28, 2020</last_update_submitted>
  <last_update_submitted_qc>December 28, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 20, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Kristen Knutson</investigator_full_name>
    <investigator_title>Associate Professor, Center for Circadian and Sleep Medicine, Department of Neurology, Northwestern University Feinberg School of Medicine</investigator_title>
  </responsible_party>
  <keyword>diabetes</keyword>
  <keyword>sleep</keyword>
  <keyword>circadian rhythm</keyword>
  <keyword>light treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Chronobiology Disorders</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <provided_document_section>
    <provided_document>
      <document_type>Study Protocol, Statistical Analysis Plan, and Informed Consent Form</document_type>
      <document_has_protocol>Yes</document_has_protocol>
      <document_has_icf>Yes</document_has_icf>
      <document_has_sap>Yes</document_has_sap>
      <document_date>May 3, 2018</document_date>
      <document_url>https://ClinicalTrials.gov/ProvidedDocs/63/NCT03188263/Prot_SAP_ICF_000.pdf</document_url>
    </provided_document>
  </provided_document_section>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Bright Light</title>
          <description>Irradiance is 230 μW/m2 and lux is 500 lux.&#xD;
Bright Light: 1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance is 230 μW/m2 and lux is 500 lux.</description>
        </group>
        <group group_id="P2">
          <title>Dim Light</title>
          <description>irradiance is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux&#xD;
Dim Light: 1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance in this dimmed is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="10"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="6"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="4"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Withdrawal by Subject</title>
              <participants_list>
                <participants group_id="P1" count="3"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
            <drop_withdraw_reason>
              <title>Physician Decision</title>
              <participants_list>
                <participants group_id="P1" count="1"/>
                <participants group_id="P2" count="0"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>There were no participants enrolled into the dim light condition.</population>
      <group_list>
        <group group_id="B1">
          <title>Bright Light</title>
          <description>Irradiance is 230 μW/m2 and lux is 500 lux.&#xD;
Bright Light: 1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance is 230 μW/m2 and lux is 500 lux.</description>
        </group>
        <group group_id="B2">
          <title>Dim Light</title>
          <description>irradiance is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux&#xD;
Dim Light: 1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance in this dimmed is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="10"/>
            <count group_id="B2" value="0"/>
            <count group_id="B3" value="10"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>&lt;=18 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Between 18 and 65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="9"/>
                    <measurement group_id="B3" value="9"/>
                  </measurement_list>
                </category>
                <category>
                  <title>&gt;=65 years</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="52.1" spread="8.0"/>
                    <measurement group_id="B3" value="52.1" spread="8.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="6"/>
                    <measurement group_id="B3" value="6"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="4"/>
                    <measurement group_id="B3" value="4"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Ethnicity (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Not Hispanic or Latino</title>
                  <measurement_list>
                    <measurement group_id="B1" value="8"/>
                    <measurement group_id="B3" value="8"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Race (NIH/OMB)</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>American Indian or Alaska Native</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Asian</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Native Hawaiian or Other Pacific Islander</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Black or African American</title>
                  <measurement_list>
                    <measurement group_id="B1" value="7"/>
                    <measurement group_id="B3" value="7"/>
                  </measurement_list>
                </category>
                <category>
                  <title>White</title>
                  <measurement_list>
                    <measurement group_id="B1" value="2"/>
                    <measurement group_id="B3" value="2"/>
                  </measurement_list>
                </category>
                <category>
                  <title>More than one race</title>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B3" value="0"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Unknown or Not Reported</title>
                  <measurement_list>
                    <measurement group_id="B1" value="1"/>
                    <measurement group_id="B3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="10"/>
                    <measurement group_id="B3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Hemoglobin A1c (%), Continuous</title>
          <units>% of hemoglobin bound to glucose</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="6.0" spread="0.2"/>
                    <measurement group_id="B3" value="6.0" spread="0.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Body mass index</title>
          <units>kg/m^2</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="34.5" spread="7.1"/>
                    <measurement group_id="B3" value="34.5" spread="7.1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change in Glucose Levels (Area-under-the-curve) Measured by Performance on Oral Glucose Tolerance Test (OGTT)</title>
        <description>The OGTT is a 3-hour procedure measuring blood glucose levels after the patient has consumed a 75-gram dextrose solution at -15 min, 0 min, 30 min, 60 min, 90 min, 120 min, and 180 min intervals. Total area-under-the-curve of glucose levels is calculated.</description>
        <time_frame>Change from baseline to after 4 weeks of light treatment</time_frame>
        <population>There were no participants enrolled into the dim light condition.</population>
        <group_list>
          <group group_id="O1">
            <title>Bright Light</title>
            <description>Irradiance is 230 μW/m2 and lux is 500 lux.&#xD;
Bright Light: 1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance is 230 μW/m2 and lux is 500 lux.</description>
          </group>
          <group group_id="O2">
            <title>Dim Light</title>
            <description>irradiance is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux&#xD;
Dim Light: 1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance in this dimmed is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux</description>
          </group>
        </group_list>
        <measure>
          <title>Change in Glucose Levels (Area-under-the-curve) Measured by Performance on Oral Glucose Tolerance Test (OGTT)</title>
          <description>The OGTT is a 3-hour procedure measuring blood glucose levels after the patient has consumed a 75-gram dextrose solution at -15 min, 0 min, 30 min, 60 min, 90 min, 120 min, and 180 min intervals. Total area-under-the-curve of glucose levels is calculated.</description>
          <population>There were no participants enrolled into the dim light condition.</population>
          <units>mg*h/dL</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="6"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-11.3" spread="11.0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The primary planned analyses was to examine effect in bright light group. A significance level of .05 was selected a priori.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The primary planned analysis was in bright light group only and compared pre-post measurements.</non_inferiority_desc>
            <p_value>.046</p_value>
            <p_value_desc>A threshold of .05 was selected a priori.</p_value_desc>
            <method>Sign test</method>
            <method_desc>A Wilcoxon matched-pairs signed-ranks test was estimated to determine if pre-post measures of glucose levels differed significantly.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Changes in Circadian Phase Measured by Dim Light Melatonin Onset (DLMO)</title>
        <description>The DLMO is measured via saliva samples collected during laboratory sessions. A sample is collected every half hour until bedtime starting 6.5 hours before habitual bedtime, and conducted in dim light setting to identify the point when melatonin starts being released.</description>
        <time_frame>Change from baseline to after 4 weeks of light treatment.</time_frame>
        <population>There were no participants enrolled into the dim light condition. In addition, one participant in the bright light condition was missing a valid DLMO measurement.</population>
        <group_list>
          <group group_id="O1">
            <title>Bright Light</title>
            <description>Irradiance is 230 μW/m2 and lux is 500 lux.&#xD;
Bright Light: 1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance is 230 μW/m2 and lux is 500 lux.</description>
          </group>
          <group group_id="O2">
            <title>Dim Light</title>
            <description>irradiance is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux&#xD;
Dim Light: 1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance in this dimmed is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux</description>
          </group>
        </group_list>
        <measure>
          <title>Changes in Circadian Phase Measured by Dim Light Melatonin Onset (DLMO)</title>
          <description>The DLMO is measured via saliva samples collected during laboratory sessions. A sample is collected every half hour until bedtime starting 6.5 hours before habitual bedtime, and conducted in dim light setting to identify the point when melatonin starts being released.</description>
          <population>There were no participants enrolled into the dim light condition. In addition, one participant in the bright light condition was missing a valid DLMO measurement.</population>
          <units>hours</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="5"/>
                <count group_id="O2" value="0"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="-0.6" spread="1.9"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
            </group_id_list>
            <groups_desc>The primary planned analyses was to examine effect in bright light group. A significance level of .05 was selected a priori.</groups_desc>
            <non_inferiority_type>Other</non_inferiority_type>
            <non_inferiority_desc>The primary planned analysis was in bright light group only and compared pre-post measurements.</non_inferiority_desc>
            <p_value>.35</p_value>
            <p_value_desc>A threshold of .05 was selected a priori.</p_value_desc>
            <method>Sign test</method>
            <method_desc>A Wilcoxon matched-pairs signed-ranks test was estimated to determine if pre-post measures of glucose levels differed significantly.</method_desc>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <time_frame>4 weeks</time_frame>
      <desc>There were no participants enrolled in the dim light group and therefore there was no one at risk.</desc>
      <group_list>
        <group group_id="E1">
          <title>Bright Light</title>
          <description>Irradiance is 230 μW/m2 and lux is 500 lux.&#xD;
Bright Light: 1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance is 230 μW/m2 and lux is 500 lux.</description>
        </group>
        <group group_id="E2">
          <title>Dim Light</title>
          <description>irradiance is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux&#xD;
Dim Light: 1 hour daily morning light treatment provided through a head-worn device for 4 weeks with the following settings: irradiance in this dimmed is reduced from 230 μW/m2 to 3 μW/m2, and lux reduced from 500 lux to 7 lux</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, all-cause mortality</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>5</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="10"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>Principal Investigators are NOT employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>Our planned enrollment goal was 14 participants in each group and therefore we were underpowered in the bright light group to detect changes in all outcome measures. Further, we were not able to perform secondary analyses, which included between group comparisons.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Kristen Knutson</name_or_title>
      <organization>Northwestern University</organization>
      <phone>312-503-1526</phone>
      <email>kristen.knutson@northwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

